New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience

GlobeNewsWire • May 28, 2026

Progyny, Inc. Announces Share Repurchase Program

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock. The program will be funded through available cash balances.

GlobeNewsWire • May 26, 2026

Progyny, Inc. (PGNY) Shareholder/Analyst Call Transcript

Progyny, Inc. (PGNY) Shareholder/Analyst Call Transcript

Seeking Alpha • May 21, 2026

Bull of the Day: Progyny (PGNY)

For growth investors seeking exposure to a differentiated healthcare disruptor with strong secular tailwinds, Progyny (PGNY) stock deserves a close look.

Zacks Investment Research • May 18, 2026

Progyny, Inc. (PGNY) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Progyny, Inc. (PGNY) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • May 12, 2026

Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that Progyny's Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026, at 11:20 A.M. Pacific Time / 2:20 P.M. Eastern Time.

GlobeNewsWire • May 11, 2026

3 Highly Ranked Medical Stocks to Buy Now: DVA, GMED, PGNY

These highly ranked medical stocks have been capitalizing on their sales expansion, and their defensive or secular growth profiles could become even more attractive if an economic downturn emerges.

Zacks Investment Research • May 11, 2026

Progyny Q1 Earnings Call Highlights

Progyny NASDAQ: PGNY reported what management called a strong start to 2026, with first-quarter revenue reaching a record level and profitability exceeding expectations amid continued investments in its platform and member experience.

MarketBeat • May 8, 2026

Progyny, Inc. (PGNY) Q1 2026 Earnings Call Transcript

Progyny, Inc. (PGNY) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 8, 2026

Progyny, Inc. Announces First Quarter 2026 Results

Reports Record First Quarter Revenue of $328.5 MillionEarly Selling Season Activity Reflects Robust Demand for Women's Health and Family Building SolutionsReturned Value to Shareholders Through Repurchase of 8.8 Million Shares to Date Since November NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, today announced its financial results for the three-month period ended March 31, 2026 (“the first quarter of 2026”), as compared to the three-month period ended March 31, 2025 (“the first quarter of 2025” or “the prior year period”). “We're pleased with the strong start to the year, as member engagement trended to the higher end of our expectations, reflecting that people are pursuing the services they need in order to address their family building and overall health and well-being goals,” said Pete Anevski, Chief Executive Officer of Progyny.

GlobeNewsWire • May 7, 2026